Treatment for breast cancer today has changed from 10 and even 5 years ago, thanks to ongoing research. At Dartmouth Cancer Center, there are 35 researchers, scientists and clinicians focused on breast cancer. Cutting-edge advances are leading to new treatment strategies.
As breast medical oncologist and researcher Gary N. Schwartz, MD, relates, being in a clinical trial today, “might well be better than treatment you would get with standard-of-care.” This is true for one patient who realized there was hope when her breast cancer returned.
In a Prouty-funded research project, Dartmouth Cancer Center researchers knowing that the most common breast cancer is driven by estrogen wanted to see if alternating high-dose estrogen and blocking estrogen would be beneficial for those with metastatic breast cancer.